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Summary
Calorie restriction (CR) is a dietary regimen that supports healthy aging. In this
study, we investigated the systemic and liver-specific responses caused by a diet
switch to a medium-fat (MF) diet in 24-month-old lifelong, CR-exposed mice. This
study aimed to increase the knowledge base on dietary alterations of gerontological
relevance. Nine-week-old C57BL/6J mice were exposed either to a control, CR, or
MF diet. At the age of 24 months, a subset of mice of the CR group was trans-
ferred to ad libitum MF feeding (CR-MF). The mice were sacrificed at the age of
28 months, and then, biochemical and molecular analyses were performed. Our
results showed that, despite the long-term exposure to the CR regimen, mice in the
CR-MF group displayed hyperphagia, rapid weight gain, and hepatic steatosis. How-
ever, no hepatic fibrosis/injury or alteration in CR-improved survival was observed
in the diet switch group. The liver transcriptomic profile of CR-MF mice largely
shifted to a profile similar to the MF-fed animals but leaving ~22% of the 1,578 dif-
ferentially regulated genes between the CR and MF diet groups comparable with
the expression of the lifelong CR group. Therefore, although the diet switch was
performed at an old age, the CR-MF-exposed mice showed plasticity in coping with
the challenge of a MF diet without developing severe liver pathologies.
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1 | INTRODUCTION
Aging has been described as an important risk factor for most
chronic diseases, largely due to the impaired capacity to maintain
homeostasis and resilience against environmental stress or damage
at old age. For the liver, aging has been associated with an increas-
ing risk to develop nonalcoholic fatty disease (NAFLD) (Argo,
Northup, Al-Osaimi, & Caldwell, 2009; Frith, Day, Henderson, Burt,
& Newton, 2009). NAFLD covers a spectrum of liver diseases
ranging from simple steatosis to nonalcoholic steatohepatitis (NASH),
fibrosis, and cirrhosis. While hepatic steatosis is considered to be
benign, NASH is the more severe condition that is characterized by
inflammation and possibly, fibrosis. Aging has been linked to NAFLD
development through a number of commonly shared molecular
mechanisms associated with both the NAFLD/NASH development
and hallmarks of aging, for example, reactive oxygen species forma-
tion, DNA damage, and hepatocyte senescence (Lopez-Otın, Blasco,
Partridge, Serrano, & Kroemer, 2013). Aging and NAFLD are also
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intertwined with the modern obesogenic environment. The preva-
lence of obesity has been shown to increase at older age (Ford,
Giles, & Dietz, 2002). Commonly observed consequences of obesity
are elevated plasma insulin and free fatty acid levels. Due to these
changes, free fatty acid uptake and triglyceride production in the
liver increase, leading to the development of NAFLD (Karpe,
Dickmann, & Frayn, 2011).
Calorie restriction (CR), a diet regimen of reduced energy intake
without malnutrition, has been shown in numerous animal studies as
by far the most effective approach to extend lifespan and to prevent
age-related and metabolic diseases (De Cabo, Carmona-Gutierrez,
Bernier, Hall Michael, & Madeo, 2014; Fontana & Partridge, 2015).
Research on CR in humans has not been conclusive, but provides
clues that beneficial metabolic adaptations observed in model spe-
cies also occur in humans (Fontana, Partridge, & Longo, 2010; Mer-
cken et al., 2013). The application of CR has been reported to be
beneficial for liver health, by improving insulin sensitivity and reduc-
ing triglyceride accumulation in the liver (Eckard et al., 2013; Kirk
et al., 2009).
To obtain health benefits of CR, a lifelong application of CR is
required. In practice though, permanently reducing calorie intake is
challenging for most individual, especially in an obesogenic environ-
ment prone to overfeeding. Only a very few individuals take up a
CR regimen voluntarily, and even then, the feasibility of adhering to
a CR diet is questionable. It has been shown in human intervention
studies that adherence to CR decreases over time (Racette, 2006)
and even a 5-day-a-month CR regimen showed a dropout rate of
25% (Wei, 2017). This implies that people that have undertaken a
CR regimen often return to an obesogenic diet. Studies concerning
the response of long-term calorie-restricted subjects to ad libitum
feeding are still limited, in particular the liver-specific responses and
NAFLD development at metabolic and transcriptomic level. A few
mice studies were performed to model the long-term CR situation.
Giller and coworkers showed that the effects of 6-month CR on adi-
posity, lipid profile in plasma and liver, and gene expression level
completely diminish within 2 weeks of control diet feeding in
C57BL/6JRj mice (Giller et al., 2013). Furthermore, a liver transcrip-
tomic study by Dhahbi and colleagues reported that in 34-month-old
B6C3F1 mice exposed to a CR diet for 21 months, 90% of the CR-
induced changes in gene expression in the liver disappear within
8 weeks of control diet feeding (Dhahbi, Kim, Mote, Beaver, &
Spindler, 2004).
In this study, we investigate the consequences of 4-month expo-
sure to a Western diet after lifelong acquaintance to a CR diet. The
CR regimen started at young age (2 months) and continued till old
age (24 months), in order to model lifelong exposure to a CR diet.
Between 24 and 28 months of age, we exposed a subset of mice in
the CR group to an ad libitum medium-fat (MF) diet, thereby gener-
ating a CR-MF diet switch group. In the sacrificed 28-month-old
mice, we investigated the systemic responses and NAFLD develop-
ment following the diet switch at a physiological, metabolic, and
molecular level. We explored both the plasticity of the mice at old
age and the persistency of the effects caused by a lifelong CR diet.
2 | RESULTS
2.1 | Switching from a CR to MF diet at old age
caused increasing body adiposity without affecting
survival
Nine-week-old C57BL/6J mice were randomly divided over three
intervention groups and exposed to a control (C), calorie restriction
(CR), or medium-fat (MF) diet. At the age of 24 months, we replaced
the diet of a subset of the CR intervention group by ad libitum expo-
sure to the MF diet (CR-MF diet switch) (Figure 1a). All mice were
sacrificed at the age of 28 months. Figure 1b shows that, at the time
point of the diet switch, the body weights of the C and MF-exposed
mice were substantially higher than those of the CR-exposed mice.
Following the transfer to the MF diet, the body weight of the CR
mice dramatically increased (Figure 1b), reaching a new plateau at
27 months of age. At sacrifice, the body weight of the CR-MF diet
switch group was significantly higher than that of the lifelong CR-
fed mice, comparable to that of the C group, but still significantly
lower than that of the MF-exposed mice.
Food intake was recorded bimonthly and revealed that, transfer-
ring mice from the CR intervention group to ad libitum MF feeding,
resulted in severe hyperphagia. Food intake of the CR-MF group at
the age of 26 months was even slightly higher than that of the life-
long MF intervention group (Figure 1c), although the difference was
not significant (Fig. S1a). However, at the age of 28 months, when
the body weight gain was stabilized at a new plateau, food intake of
the CR-MF mice decreased to similar amounts as consumed by the
C intervention group.
Weight measurement of the epididymal white adipose tissue
(eWAT) and liver revealed significant increases in the CR-MF group
compared with the lifelong CR-exposed mice (Fig. S1b). However,
after normalization to body weight, a significant increase was
observed in the CR-MF group only in relative eWAT weight, while
no significant difference was found for the relative liver weight
(Figure 1d).
As CR is known to protect against aging-related low-grade sys-
temic inflammation, which is also called inflammaging (Franceschi
et al., 2000), a panel of 16 inflammatory markers, including inter-
feron gamma (IFNc), tumor necrosis factor (TNF), interleukin-1a
(IL-1a), IL-1b, IL-2, IL-6, IL-7, IL-10, IL-15, chemokine (C-C motif)
ligand 2 (CCL2 or MCP1), CCL3 (MIP-1a), CCL4 (MIP-1b), CCL5
(RANTES), chemokine (C-X-C motif) ligand 1 (CXCL1 or KC), CXCL9
(MIG), and CXCL10 (IP-10), was measured in plasma to characterize
the inflammatory status following the exposure to MF diet. The prin-
cipal component analysis (PCA) plot presented in Figure 1e revealed
that the plasma inflammatory profile of the CR-MF switched animals
had shifted into the direction of the C-fed mice.
The survival rate recorded between 24 and 28 months revealed
that mortality of the CR-MF diet switch group was equivalent to the
lifelong CR-exposed mice and strongly different from the C and MF
intervention groups (Figure 1f). Therefore, despite the changes in
whole-body adiposity, the improved survival gained in the CR period
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was successfully maintained during the 4-month exposure to the MF
diet.
2.2 | The liver transcriptome of the CR-MF diet
switch mice strongly shifted to the MF profile
To investigate the diet switch effect on the liver transcriptome of
the CR-MF diet group, a microarray analysis was performed. A PCA
was carried out, using the C diet group as the reference. The results
presented in Figure 2a show a remarkable shift in the transcriptome
profile of the CR-MF diet switch group from the CR toward the MF-
exposed mice. Notably, the interindividual variability in the MF diet
group and in particular the CR-MF group was much higher than in
the CR group.
Although a pronounced switch in the transcriptomic profile of
the CR-MF-exposed animals from the lifelong CR group was
detected, the diet switch did not result in a complete overlap with
the expression profile of the MF-exposed group. To investigate
which genes in the CR-MF expression profile remained similarly
expressed with that of the lifelong CR-exposed mice, we applied the
following gene screening (Figures 2b and S2a). We first identified
the differentially expressed genes between the lifelong CR and MF
groups (p < .01), which resulted in a list of 1,578 genes. Then, to
determine which of these 1,578 genes remained comparable to the
CR-exposed mice after the CR-MF switch and significantly different
to those of the MF diet group, we screened for the genes (i) display-
ing no differential expression between the CR-MF and CR groups
(p ≥ .05) and (ii) displaying significant (p < .01) difference in expres-
sion between the CR-MF and MF intervention groups. The direction
of the fold change was also checked to confirm that the CR-MF and
CR groups show the same direction of change in comparison to the
MF group. A subset of 354 “CR-associated genes” were identified,
exhibiting similar expression in the CR and CR-MF groups.
Figure S2b visualizes the expression levels of the 354 CR-associated
genes in the individual CR-, CR-MF- and MF-exposed mice. Overall,
we showed that, following the CR-MF diet switch, 354 genes
remained similarly expressed with the lifelong CR-exposed mice
(~22% of the 1,578 genes), while the majority (~78% of the 1,578
genes) adapted to the MF expression profile.
2.3 | Functional characterization of the CR-
associated genes in the liver
Ingenuity pathway analysis (IPA) was applied to explore which
canonical pathways were represented by the 1,578 genes displaying
differentially expression between the CR and MF intervention
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F IGURE 1 Physiological changes during the CR-MF diet switch. (a) Experimental design. (b) Body weight development from 24 to
28 months of age following the diet switch. (c) Food intake measurement at 24, 26, and 28 months. (d) eWAT and liver weight. (e) Principle
component analysis of 16 plasma inflammatory cytokines. (f) Kaplan–Meier survival curve, statistical difference was assessed by log-rank
analysis. *p < .05; **p < .01; ***p < .001
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groups. The 10 most significantly different canonical pathways listed
in Table S1 revealed highly significant regulation of various pathways
commonly acknowledged to be affected by CR, including mitochon-
drial dysfunction, oxidative phosphorylation, and apoptosis signaling.
Next, we assigned the gene members in each pathway as a CR-asso-
ciated or MF-adapted gene, according to the above-explained crite-
ria. The results presented in Figure 2c show that the pathways
containing a relative high percentage of CR-associated genes were
found to be related to disease progression, for example, sphingosine-
1-phosphate signaling, apoptosis, hepatic fibrosis/hepatic stellate cell
activation. Meanwhile, oxidative phosphorylation and mitochondrial
dysfunction, both of which are pathways related to energy utiliza-
tion, only contained a small fraction of the CR-associated genes (4%
and 6%, respectively). This suggests that, following the CR-MF diet
switch, pathways related to energy utilization largely adapted to the
expression profile of the MF diet group. In addition, these results
suggest that the CR-associated genes in the CR-MF diet switch
group are not confined to a specific pathway. We extended the anal-
ysis to CR-regulated key metabolic pathways, which are known to
be energy/nutrient sensing-dependent (Anderson & Weindruch,
2010). PCA performed on AMPK, PI3K/AKT and insulin-IGF (Fig. S3)
signaling gene sets revealed that the expression profile of the CR-
MF diet switch mice again strongly shifted from the CR profile
toward the lifelong MF cluster.
2.4 | Identification of upstream regulators of the
CR-associated genes in the liver
Next, by applying IPA, we searched for predicted upstream regula-
tors of the 354 CR-associated genes. This analysis corroborates
expression changes from multiple genes, which decreases the likeli-
hood that any one that might be rendered insignificant by post-tran-
scriptional regulation would lead to a misleading biochemical/
physiological surmise. The results presented in Table 1 show the top
10 predicted upstream regulators revealing highly significant p-values
(1010–103). We observed that the regulators related to hepatic
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TABLE 1 Upstream regulators of the 354 CR-associated genes
Top 10
upstream
regulator
Target
genes (n) p-value*
Activation
z-scorea
Predicted
activation
statea
ACOX1 17 1.32 9 1010 3.153 Activated
TGFb1 59 1.40 9 109 3.581 Inhibited
AHR 19 1.04 9 106 2.523 Activated
IL-1b 32 3.82 9 106 2.774 Inhibited
COMMD1 5 1.56 9 105 2.236 Activated
Alpha-catenin 10 1.94 9 105 2.618 Activated
BTNL2 8 2.61 9 105 2.121 Inhibited
HIF1a 16 2.04 9 104 2.140 Inhibited
ERK 11 9.71 9 104 2.121 Inhibited
CD44 9 1.06 9 103 2.449 Inhibited
*Based on previous knowledge of expected effects between upstream reg-
ulators and their target genes in the IPA database, upstream regulator anal-
ysis was performed. Top 10 predicted upstream regulators are presented.
aAnother standard statistical measure in upstream regulator analysis in
IPA is activation z-score. The known effect (activation or inhibition) of an
upstream regulator was compared with observed changes in gene
expression. Based on the concordance between the two, an activation
z-score was determined, showing whether the predicted upstream regu-
lator was activated (z-score >2), inhibited (z-score <2) or uncertain.
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fibrosis including transforming growth factor b1 (TGFb1), interleukin-
1b (IL-1b), and hypoxia-inducible factor 1-a (HIF1a) were inhibited
(activation z-score <2.000). Two of these regulators, IL-1b and
HIF1a, are also related to inflammation. Furthermore, acyl-CoA oxi-
dase 1 (ACOX1), which has been previously linked to NAFLD for its
role in lipid metabolism, was predicted to be activated. ACOX1 activ-
ity represents fat oxidation, which helps to prevent the accumulation
of fat in the liver.
2.5 | Development of hepatic steatosis, but no
hepatic fibrosis/injury, in the CR-MF diet switch group
Next, we explored the CR-MF diet switch effect on NAFLD develop-
ment in more detail. Firstly, the measurement of plasma insulin level,
one of important factors in the pathogenesis of NAFLD, revealed
that the level increased in the CR-MF mice in response to the diet
switch, but did not reach the level of the lifelong MF-exposed ani-
mals (Figure 3a). Plasma glucose levels of the animals in CR-MF diet
switch did not significantly differ from other groups (Fig. S4a). The
plasma alanine transaminase (ALT) level, a marker for liver injury,
was markedly elevated only in the lifelong MF diet group but not in
any of the other intervention groups (Figure 3b). The measurement
of hepatic steatosis, which is represented by intrahepatic triglyceride
(IHTG) content, revealed that after the diet switch the level of fat
accumulation in the liver of the CR-MF diet group significantly
increased to a level comparable to the lifelong MF-exposed mice
(Figure 3c). The measurement of liver 4-hydroxyproline content, a
marker for hepatic fibrosis, showed elevated levels in the lifelong
MF-exposed animals, but not in the CR-MF group (Figure 3d). This
result was confirmed by collagen staining of liver sections (Fig-
ures 3e and S4b). To summarize, the 4 months exposure to MF diet
resulted in elevated insulin and IHTG levels, but did not induce the
progression of NALFD to liver fibrosis and injury.
2.6 | CR-MF diet switch shifted plasma N-glycomics
profile without altering the gene expression level of
Fut8, one of the major glycosyltransferase
Previous studies have shown that plasma N-glycosylation profiles are
associated with chronic liver diseases (Blomme et al., 2011). The
results presented in Figure 4a show that all three major N-glycan
structures previously identified (Vanhooren et al., 2011), bigalactosy-
lated, biantennary glycan (NA2), agalactosylated, core-a-1,6-fucosy-
lated biantennary glycan (NGA2F) and bigalactosylated, core-a-1,6-
fucosylated biantennary glycan (NA2F), were significantly different
between the lifelong CR and MF diet groups. The levels of NA2,
NGA2F, and NA2F in the CR-MF diet group were in between those
of the CR- and MF-fed animals, but did not differ significantly from
either of the two intervention groups. Previous research has shown
that expression and activity of a-1,6-fucosyltransferase (Fut8) in the
liver were strongly associated with the plasma profiles of the three
N-glycan structures (Vanhooren et al., 2011). In our study, Fut8
expression differed significantly between CR and MF-exposed mice
(Figure 4b; confirmed by qPCR analysis in Fig. S5). However, Fut8
was one of the 354 CR-associated genes of which the expression did
not alter in response to the diet switch. We further explored other
genes involved in glycosylation biosynthesis and degradation
(Table S2) and found that a number of genes in these processes were
strongly correlated with the three N-glycan structures. Notably,
NGA2F was correlated with ribophorin I (Rpn1), NA2 with mannosyl-
oligosaccharide glucosidase (Mogs) and hexosaminidase B (Hexb), and
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NA2F with ribophorin II (Rpn2) and UDP-glucose glycoprotein gluco-
syltransferase 1 (Uggt1). Rpn1 and Rpn2 are genes in transferring gly-
cans to asparagine residues, Mogs supports the trimming of N-glycan
in endoplasmic reticulum (ER), Hexb is involved in N-glycans degrada-
tion, and Uggt1 contributes to the regulation of N-glycan quality con-
trol (Clarke, Novak, Lake, Hardwick, & Cherrington, 2017).
Interestingly, expression levels of Rpn2 and Uggt1 differed signifi-
cantly between CR and MF-exposed mice, and the CR-MF diet group
showed similar expression levels to those of the MF group (Fig-
ure 4c). Therefore, this indicates that although Fut8 did not change
following the CR to MF diet switch, the altered glycosylation was
influenced by other mechanisms involved in N-glycan biosynthesis.
2.7 | The relationship between physiological and
gene expression level in hepatic steatosis
development following the CR-MF diet switch
While IHTG levels were significantly increased in the CR-MF diet
switch group, cluster of differentiation 36 (Cd36), a key fatty acid
transporter in the development of hepatic steatosis (Sheedfar et al.,
2014), did not follow the same pattern. As one of the 354 CR-asso-
ciated genes which expression did not alter in response to the diet
switch, Cd36 displayed significant difference between the CR and MF
intervention groups but its expression did not adapt to the MF diet
after the diet switch (Figure 5a; confirmed by qPCR analysis in Fig. S5).
Other fatty acid uptake/transporter genes were explored (Fig. S6 for
genes without significant alteration), and we found that the expression
levels of caveolin 1 (Cav1) (Figure 5b; confirmed by qPCR analysis in
Fig. S4) and fatty acid binding protein 4 (Fabp4) (Figure 5b) were ele-
vated in the CR-MF diet group, implying that, while the Cd36 expres-
sion was repressed, there were alternatives for fatty acid uptake.
2.8 | Differentially methylated enhancer region was
found in the intergenic region adjacent to Cd36
As Cd36 plays an important role in the development of NAFLD, the
mechanism behind its gene repression in the CR-MF diet switch is
of biological interest. A possible mechanism underlying the Cd36
repression is by altering the DNA methylation of regions of the gene
involved in transcription regulation. To explore this possibility, we
analyzed the DNA methylation level of the promoter and enhancer
region of Cd36. Promoter and weak enhancer regions were obtained
from the mouse ChromHMM track (Ernst & Kellis, 2012) and identi-
fied to be present in the gene body and a distant upstream region,
respectively (Figures 5c and S7 for detailed chromosomal position
and epigenetic features). As shown in Figure 5d, we did not find a
significant difference for the methylation level in the promoter
region. However, the methylation levels of all 4 CpG sites analyzed
in the enhancer region were significantly higher in the MF diet group
compared to the levels in CR group (Figure 5e). Interestingly,
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although the methylation levels of the CR-MF diet switch group
were slightly increased compared to the lifelong CR mice, the methy-
lation percentage of each of the CpGs was markedly lower com-
pared to the lifelong MF-exposed animals.
3 | DISCUSSION
In this study, we aimed to investigate the systemic and liver-specific
responses of 24-month-old, lifelong CR-exposed mice to 4 months
of MF intervention. Our data revealed that in the diet switch group,
most of the CR-related features shifted to the MF profile: (i) whole-
body adiposity, (ii) hepatic steatosis, (iii) global transcriptome, and (iv)
CR-specific molecular features including IGF-1/insulin signaling,
oxidative phosphorylation, and AMPK signaling. These results show
that the CR-MF-exposed animals have great plasticity in coping with
the challenge of the MF diet. We also show that a number of CR-
related features were maintained in the CR-MF group: (i) the preven-
tion of hepatic fibrosis and injury, (ii) the improved survival, and (iii)
the expression levels of a subset of CR-related genes that were not
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altered by 4-month exposure to the MF diet. Expanding the late-life
MF diet exposure period or challenging the mice with a high-fat diet
or acute liver injury would be of interest to further explore the pro-
tective effect induced by the CR diet.
Even after a long-term exposure to the CR diet until an old age
of 24 months, the mice were not adapted to the low energy intake
and displayed extreme hyperphagia. The lifelong CR-exposed mice in
our aging cohort demonstrated their anticipation to receiving their
daily food allotment by a burst in their activity level just prior to the
regularly scheduled feeding (Van Norren et al., 2015). The hyper-
phagic response is an indicator that hunger persists even after a
long-term CR (Hambly, Mercer, & Speakman, 2007) and is main-
tained until body weight reaches the level of the ad libitum-fed ani-
mals (Selman & Hempenstall, 2012). It is followed by a dramatic
weight gain, adipose tissue expansion, and hepatic steatosis. This
depicts a thrifty “catch-up fat” characteristic, in which metabolic pro-
cesses have evolved to be efficient in storing excessive energy once
an energy supply is available (Barnes & Ozanne, 2011). Therefore,
our experiment indicates that a lifelong application of the CR regi-
men is not able to acclimatize the mice to low energy intake and to
resist the thriftiness, when the food availability is no longer
restricted. The fact that the mice, even after lifelong exposure to a
CR diet, are still not adjusted to the low-calorie intake is something
to take into consideration with regard to the human situation. If a
constant hunger experience is the side effect of a CR diet, even at
the long run, it can be questioned whether this suffering is compen-
sated for by living a long and healthy life. Our results endorse the
search for alternatives to CR regimen, in which food restriction is
not continuously applied, for example, intermittent CR (Brandhorst
et al., 2015; Rusli et al., 2015, 2017); or CR-mimetics (Gillespie, Pick-
ering, & Eskiw, 2016; Ingram & Roth, 2015), compounds that pro-
duces CR-like effects on longevity without requiring the reduced
food intake.
Food intake measurements revealed an unanticipated increase in
MF diet group between 26 and 28 months of age, which was con-
trary to the typically decreasing intake at old age (Hamrick et al.,
2006). In a study that compares young and old mice, it was revealed
that the old mice drop significantly more food than the young ones,
which possibly contributed to age-related decline in oral motor func-
tion and/or dentition and/or joint impairment (Starr & Saito, 2012).
Therefore, the correction for small pieces of food pellets spoiled in
the cages could be crucial to avoid an overestimation of the food
intake at old age.
Following the CR-MF diet switch, the beneficial effects of a CR
diet on the liver transcriptomic profile changed dramatically, confirm-
ing the results of previous investigations (Dhahbi et al., 2004; Giller
et al., 2013). This could be explained by the dependence of a num-
ber of CR-mediated pathways (e.g., oxidative phosphorylation, AMPK
signaling) on energy depletion/stress (Burkewitz, Zhang, & Mair Wil-
liam, 2014). Despite the pronounced alteration of the transcriptomic
profile, in our study, we found a set of 354 CR-associated genes,
which expression remained to be comparable with the expression
levels of the lifelong CR intervention group. Possible explanations
for this difference include the experimental settings, that is, mouse
strains, the varying length of exposure to CR, severity of calorie
reduction, type of diets used, age of mice at time point of observa-
tion, the use of different microarray platforms with different
amounts of annotated genes (B6C3F1 mice, 44E% CR from 7 till
32 months, micronutrients supplementation to reach adequate level
was not specified, fed at the beginning of light phase, followed by
8 weeks of control AIN-93M diet, Affymetrix Mu11K sets A and B
oligonucleotide arrays in Dhahbi et al. (2004); C57BL/6JRj mice,
25E% CR with micronutrients supplementation from 6 to 8 weeks of
age for 6 months, followed by 6 months of Standard diet, Agilent
Sure Print G3 Mouse Gene Expression 8x60K Arrays in Giller et al.
(2013); C57BL/6J mice, 30E% CR with micronutrients supplementa-
tion from 2 till 24 months, followed by 4 months of MF diet, Affy-
metrix GeneChip Mouse Gene 1.1 ST arrays in this study).
One of the most intriguing findings in the current study emerged
when we investigated to what extent the CR-associated genes are
linked to their related phenotypes. Previous studies on Fut8 hepatic
expression and plasma glycosylation profile show the modulation of
Fut8 expression and NGA2F, NA2, and NA2F plasma levels during
aging and chronic liver diseases (Blomme et al., 2011; Vanhooren
et al., 2011). Expression of this gene did not alter during the 4-
month exposure to MF diet, but a slight shift in the fucosylated N-
glycan levels, NGA2F and NA2F, in the plasma was observed. We
found that other genes (Rpn1, Rpn2, Mogs, Hexb, Uggt1), which are
all involved in other key steps in N-glycan biosynthesis/processing,
might be responsible for the altered glycosylation profile in the CR-
MF diet switch group. As hepatic steatosis has been reported to dis-
turb the function of ER in hepatocytes (Baiceanu, Mesdom, Lagouge,
& Foufelle, 2016), the fact that the mice exposed to CR-MF diet
switch developed hepatic steatosis might contribute to ER stress and
stress responses which consequently affected N-glycan processing in
the ER. Another possibility is the presence of other fucosyltrans-
ferases, such as Fut2 and Fut3 in the gut (Drake et al., 2010), which
leads to plasma glycosylation profile modification by multiple tissues.
Another intriguing discrepancy in gene expression and physiolog-
ical outcome is the hepatic expression of Cd36, a fatty acid transport
gene which overexpression increases susceptibility to accumulate
liver fat (Koonen et al., 2007; Sheedfar et al., 2014). The deletion of
this gene has previously been shown to cause resistance to diet-
induced hepatic steatosis (Clugston et al., 2014). In our study, we
found that, despite of the development of hepatic steatosis, the
expression of Cd36 in the CR-MF group remains low, comparable to
the expression levels in the lifelong CR diet group. The role of fatty
acid transport was seemingly compensated by increased expression
of Cav1 and Fabp4. This demonstrates that, after lifelong exposure
to a CR diet, the system is still plastic and can adapt to a MF diet,
but that alternative genes might be used when a certain function
needs to be carried out.
Furthermore, we found that the methylation status of the far
upstream enhancer (~40 kbp from the transcription start site), but
not of the promoter region of the Cd36 was affected by the MF
diet. Although this observation implies that changes in DNA
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methylation might be responsible for the altered expression levels of
the Cd36, our results remain inconclusive. First of all, the methyla-
tion levels of the CR-MF diet switch group are in between those of
the CR and MF groups, while the expression levels remain similar to
those of the lifelong CR-exposed mice. Secondly, in the MF inter-
vention group, both gene expression and methylation levels of the
enhancer region of Cd36 were significantly increased, compared to
the CR-fed mice. Decreased CD36 expression together with
decreased DNA methylation has recently been shown in response to
a hypocaloric diet-induced weight loss in female subjects (Do
Amaral, Milagro, Curi, & Martınez, 2014). Similar to what we
observed, this study showed that gene expression and DNA methy-
lation levels are positively associated. However, the results pre-
sented in the study show differential methylation region close to the
transcription start site, while in our study, methylation of the enhan-
cer was altered. Further studies are required to unravel the relation
between gene expression and DNA methylation for the Cd36 gene.
To conclude, despite a long term of adulthood CR (22 months),
the CR-MF mice did not become metabolically or physiologically
implacably fixed in the state of functioning that CR engendered. The
CR-MF diet switch group developed hyperphagia causing weight
gain and hepatic steatosis. Furthermore, the liver transcriptomic pro-
file of CR-MF group largely shifted to a profile similar to the MF-fed
animals, leaving only ~22% of the 1,578 differentially regulated
genes between the CR and MF diet groups comparable with the
expression of the lifelong CR group. As illustrated by the analysis of
Cav1, Fabp4, and Cd36 expressions and their relations with hepatic
steatosis, the liver has a robust metabolic network that includes mul-
tiple regulators contributing its plasticity in coping with the challenge
of MF diet. Therefore, although the diet switch was performed at an
old age, the CR-MF-exposed mice showed plasticity in adapting to
the MF diet without developing severe liver pathologies, which likely
contributes to the maintenance of the CR-improved survival.
4 | MATERIAL AND METHODS
4.1 | Ethics statement
The institutional and national guidelines for the care and use of ani-
mals were followed and the Local Committee for Care and Use of
Laboratory Animals at Wageningen University approved the experi-
ment (code number: drs-2010151b).
4.2 | Animals and diets
The animal study was a part of a mice aging cohort (Rusli et al.,
2015, 2016). Male C57BL/6J mice (Janvier, Cedex, France) arrived at
7 weeks of age and allowed to acclimate for 2 weeks, receiving
standard AIN-93G (Research Diet Services, Wijk bij Duurstede, the
Netherlands) upon arrival. At the start of the diet intervention, the
mice were 9 weeks old and randomly distributed into three interven-
tion groups: (i) Control diet receiving AIN-93W diet ad libitum
(n = 89); (ii) CR diet receiving AIN-93W-CR in portions containing
70E% of the mean energy intake of the group of the control mice
were provided each day at 15.30 (n = 117); (iii) medium-fat diet
(MF) receiving AIN-93W-MF ad libitum (n = 127). AIN-93W-CR con-
tained increased concentration of vitamins and minerals content to
feed these mice the same concentrations of micronutrients as the
mice receiving AIN-93W diet and avoid malnutrition. Complete diet
composition is listed in Table S3 (Research Diet Services, Wijk bij
Duurstede, the Netherlands). All mice were provided with ad libitum
access to water. The mice were housed individually in the light and
temperature (20°C)-controlled animal facility of Wageningen Univer-
sity (12-h light/dark cycle, light on at 04.00).
The long-term dietary invention was continued until a sacrifice at
the age of 28 month, but in addition to the three diet groups, at
24 month, the animals in the CR diet group were randomly assigned
either to remain on the CR diet (n = 30) or undergo a diet switch to
the MF diet (n = 32). This resulted in a group of 25–32 animals in
each group at 24 months. Anticipating that the animals would not
be used to ad libitum feeding after exposure to CR for a long term,
the food intake was increased gradually, by addition of 10E% per
week. Therefore, it took 3 weeks for the animals to be allowed to
have MF ad libitum. Body weight of all mice was recorded weekly.
Food intake of 20 mice of each intervention group was measured
every 2 months. Portion sizes of the mice on the CR were based on
the mean food intake of the C-exposed mice measured for 7 days.
At the age of 28 months, 8–11 mice of each intervention group
were sacrificed between 14.00 and 17.00 on three consecutive
weeks. Prior to sacrifice, each mouse was first fasted for 4 hr after
which they received an intragastric gavage of either Wy-14,643
(Wy) substance solved in 0.5% carboxymethyl cellulose (CMC) or just
the 0.5% CMC solvent and then fasted again for another 6 hr. All
mice were used for the phenotypic measurements (bodyweight, food
intake, etc.). The aim of the Wy-treatment was to perform a PPARa
adaptive capacity analysis, which has been covered in a separate
publication (Rusli et al., 2016). As Wy-treatment causes an effect on
gene expression level, these animals were not included in the tran-
scriptomic analysis. After sedation with isoflurane (1.5%), in a mix-
ture of nitrous oxide (70%) and oxygen (30%), blood samples were
collected by cardiac puncture, then followed by neck dislocation.
Weight of various organs was measured and snap-frozen and stored
at 80°C until further molecular/biochemical analysis.
4.3 | Plasma and liver markers analyses
Plasma IL-6 and CCL2 levels were measured using a Mouse Adipo-
kine (MADKMAG-71K) kit, while plasma IFNc, TNF, IL-1a, IL-1b, IL-
2, IL-7, IL-10, IL-15, CCL3, CCL4, CCL5, CXCL1, CXCL9 and CXCL10
from Mouse Cytokine (MCYTMAG-13K) kit (Millipore, Billerica, MA,
USA), according to the manufacturer’s instructions. Plasma glucose
was measured with Glucose GOD FS (DiaSys, Holzheim, Germany),
according to the manufacturer’s protocol. The insulin and ALT deter-
mination in the plasma, as well as the hepatic triglycerides and
hydroxyproline analysis, have been previously described (Rusli et al.,
2015, 2016).
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4.4 | Microarray hybridization
Prior to the microarray hybridization, total RNA was isolated and
checked for its quality (see Appendix S1 for details). Hybridization,
washing, and scanning of Affymetrix GeneChip Mouse Gene 1.1 ST
arrays were performed according to standard Affymetrix protocols.
Microarray analysis was performed in MADMAX, a pipeline for statis-
tical analysis of microarray data (Lin et al., 2011). Arrays were normal-
ized using the Robust Multiarray Average method (Bolstad, Irizarry,
Astrand, & Speed, 2003; Irizarry et al., 2003). Probe sets were defined
according to Dai et al. (2005). In this method, probes are assigned to
unique gene identifiers, in this case Entrez IDs. The probes on the
Gene 1.1 ST arrays represent 21,225 Entrez IDs. For the analysis, only
genes having 1) an interquartile range of entire dataset (including all
of the groups) of >0.1 and 2) an intensity value of >20 on at least five
arrays were taken into account and subsequently investigated for sta-
tistical analyses on differences between groups, which resulted in
15,417 genes in the dataset. Array data have been submitted to the
Gene Expression Omnibus, with accession number GSE102593.
For the microarray data analysis, differentially expressed probe
sets were identified using linear models (library limma) and the inten-
sity-based moderated t-statistic (IBMT) method was applied. Result-
ing log2 intensities and p-values were used for further descriptive
bioinformatic analysis of the data. Heatmap and PCA plots were
constructed using MultiExperiment Viewer version 4.8.1 (Saeed
et al., 2006) and factomineR package in R, respectively. Pathway and
upstream regulator analyses were performed in ingenuity pathway
analysis (IPA; Ingenuity Systems).
4.5 | Plasma glycomics analysis
N-glycans on the plasma glycoproteins were analyzed using DNA-
sequencer-Aided, Fluorophore-Assisted Carbohydrate Electrophore-
sis (DSA-FACE) technology. The same DSA-FACE protocol used in
(Borelli et al., 2015; Vanhooren, Laroy, Libert, & Chen, 2008) for the
analysis of the human plasma N-glycome was applied for the mouse
plasma. N-glycosylation was analyzed in 2 ll of total plasma (see
Appendix S1 for detailed procedure). Five major glycan peaks, which
had the same migration positions of the well-known human N-glycan
structures (Fig. S8), were measured using a DNA-sequencer ABI-
PRISM 3730xl (Applied Biosystem, Foster City, CA, USA).
4.6 | Bisulfite conversion and DNA methylation
analysis
Genomic DNA was isolated from the liver using the classical pro-
teinase K digestion and phenol: chloroform extraction (see
Appendix S1 for detailed preparation). Bisulfite conversion and DNA
methylation analysis by means of pyrosequencing were adapted from
a previous study (Steegenga et al., 2014). For each sample, 1,000 ng
of genomic DNA was bisulfite-treated using the EZ-96 DNA Methy-
lation™ Kit (Zymo Research, Irvine, CA, USA) and eluted in 60 ll of
TE. DNA methylation analysis was performed using PyroMark™
pyrosequencing technology (Biotage AB, Uppsala, Sweden). Primers
were designed using PyroMark software, and the sequences of the
primers used and their specific melting temperature are listed in
Table S4. The single-stranded PCR product (35 ll) is isolated and
allowed to hybridize with a sequencing primer, and pyrosequencing
was performed using the Q24 Pyrosequencing System (Qiagen,
Venlo, the Netherlands) (see Appendix S1 for detailed procedure).
CpG methylation was analyzed with the provided software.
4.7 | Statistical analysis
Statistical analysis, except for the microarray gene expression data,
was analyzed with GraphPad Prism 5.04 (Graphpad Software, La Jolla,
California, USA). Differences between dietary interventions were ana-
lyzed using one-way ANOVA followed by Tukey post-test analysis.
The alteration of DNA methylation levels in a specific region was
evaluated with two-way ANOVA followed by Bonferroni post-test
analysis. Results represented in bar graphs are shown as means 
standard deviation. For results plotted in box-and-whisker plots, the
box extends from 25th to 75th percentiles with a line at median value,
while the whiskers denote 5 and 95 percentiles. Pearson’s correlation
was used to determine the relationship between variables. Statistical
significance for the survival of groups was established by the log-rank
analysis of Kaplan–Meier plots.
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